Notably, the increase seemed to be unrelated to the etiology of liver disease, since comparable K19 mRNA levels were seen in samples from patients with NAFLD, ALD, and chronic hepatitis C (Additional file 1: Fig. S1A). This evidence concerns the gene KRT19 and metabolic dysfunction-associated steatotic liver disease.